CD8A and Miyoshi myopathy: Further, it has been demonstrated that enrichment of non-cycling, non-activated early memory CD8+ T-cells and CD4+ T-cells with early memory features in pre-manufacturing cells is a predictive biomarker of response to BCMA CAR T-cells in MM patients (151).